Opinion
1yon MSNOpinion
Given Biden’s diagnosis, what a urologist wants you to know about prostate screening
Urologist Dr. Jamin Brahmbhatt knows the complexities surrounding prostate-specific antigen testing with his patients. Here’s what to consider with the PSA test.
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
DEAR DR. ROACH: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...
PHAROS, a real-world multi-country European study on patients with high-risk localised and locally advanced prostate cancer receiving radical treatment. This is an ASCO Meeting Abstract from the 2024 ...
A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...
This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...
In a recent study published in the journal Nutrients, researchers investigated the associations between urinary bisphenol A (BPA) concentrations (exposure) and the prostate-specific antigen (PSA; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results